DA
EVO icon

DCF Advisers’s Evotec EVO Stock Holding History

DCF Advisers’s Portfolio EVO Stock Details EVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.02M Buy
1,079,024
+13,750
+1% +$39.7K 0.53% 34
2026
Q1 		$2.66M Sell
1,065,274
-133,719
-11% -$431K 0.71% 35
2025
Q4 		$3.69M Hold
1,198,993
– – 0.99% 30
2025
Q3 		$4.35M Buy
1,198,993
+84,500
+8% +$321K 1.4% 23
2025
Q2 		$4.68M Buy
1,114,493
+362,914
+48% +$1.42M 2.17% 15
2025
Q1 		$2.51M Buy
751,579
+521,708
+227% +$2.13M 1.2% 29
2024
Q4 		$956K Buy
229,871
+12,816
+6% +$53.8K 0.46% 54
2024
Q3 		$792K Buy
217,055
+102,102
+89% +$405K 0.32% 60
2024
Q2 		$552K Buy
114,953
+67,156
+141% +$377K 0.28% 63
2024
Q1 		$374K Hold
47,797
– – 0.18% 69
2023
Q4 		$561K Sell
47,797
-1,250
-3% -$12.3K 0.3% 55
2023
Q3 		$484K Buy
49,047
+6,309
+15% +$74.1K 0.26% 64
2023
Q2 		$483K Buy
42,738
+30,350
+245% +$324K 0.26% 62
2023
Q1 		$129K Buy
+12,388
New +$118K 0.08% 64

Other funds holding EVO

WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
Optiver Holding
Optiver Holding Amsterdam, Netherlands $371B AUM 64.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
OMC
Old Mission Capital Chicago, Illinois $6.31B AUM 20.77% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return
FC
Fore Capital New York $338M AUM 10.07% 1-Year Est. Return
SCA
Snowden Capital Advisors New York $4.23B AUM 29.95% 1-Year Est. Return

DCF Advisers's EVO Position: Q2 2026 in Review

DCF Advisers increased its Evotec (EVO) stake by 1.3% in Q2 2026, buying an estimated $39.7K and bringing the position to 1,079,024 shares worth $3.02M. The position accounts for 0.53% of the portfolio, ranked #34.

DCF Advisers first reported a position in EVO in Q1 2023 and has held it in 14 quarters since. The position peaked at $4.68M in Q2 2025. 34 funds tracked by Wall St. Rank hold EVO as of Q2 2026.

  • DCF Advisers held 1,079,024 shares of Evotec worth $3.02M as of Q2 2026.
  • DCF Advisers bought 13,750 Evotec shares in Q2 2026, an estimated $39.7K.
  • Evotec made up 0.53% of DCF Advisers's portfolio in Q2 2026, its #34 holding.
  • DCF Advisers first reported a position in Evotec in Q1 2023 and has held it in 14 quarters since.
  • DCF Advisers's Evotec position peaked at $4.68M in Q2 2025.
  • 34 funds tracked by Wall St. Rank held Evotec as of Q2 2026.

Based on DCF Advisers's 13F filing for Q2 2026, filed 10 Aug 2026.